Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02698787 · ClinicalTrials.gov registry record

Fundamental Asynchronous Stimulus Timing Sound Coding Study

A clinical trial of Sensorineural Hearing Loss, sponsored by Cochlear.

Completed
Registry status
11
Enrollment target
1
Study location

NCT02698787: Completed study of Sensorineural Hearing Loss, sponsored by Cochlear.

NCT02698787 is a study of Sensorineural Hearing Loss that has completed, run by Cochlear. The registered enrollment target is 11 participants, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02698787, a study of Sensorineural Hearing Loss, has completed, sponsored by Cochlear.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The Fundamental Asynchronous Stimulus Timing (FAST) is a novel cochlear implant sound coding strategy. Potential benefits include improved battery life, in addition to improved localization for bilateral patients.

Primary Outcome

Open Set Monosyllabic Word Recognition is a test of 50 words each consisting of 3 individual speech sounds. The subject repeats the word s/he hears to the audiologist. The score is based on the percentage of words correct. The primary outcome measure to is determine if the investigational sound coding strategy (FAST) is non-inferior to commercially approved sound coding strategies (ACE) for word recognition in quiet with percentage of words correct.

Conditions Studied

Interventions

  • DEVICE Experimental sound coding strategy (FAST)
  • DEVICE Commercially available ACE sound coding strategy

Study Locations (1)

Colorado

  • University of Colorado Health - Aurora

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-12
Est. Completion 2018-11-19
Cochlear

34 total trials

What the finished NCT02698787 record still lists

NCT02698787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Experimental sound coding strategy (FAST) is the first listed.

NCT02698787 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02698787 about?

NCT02698787 is a clinical study titled "Fundamental Asynchronous Stimulus Timing Sound Coding Study". The Fundamental Asynchronous Stimulus Timing (FAST) is a novel cochlear implant sound coding strategy. Potential benefits include improved battery life, in addition to improved localization for bilateral patients.

What is the current status of trial NCT02698787?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-12. Estimated completion is 2018-11-19.

What conditions does trial NCT02698787 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss.

What interventions are being tested in trial NCT02698787?

The interventions under investigation include: Experimental sound coding strategy (FAST) (DEVICE), Commercially available ACE sound coding strategy (DEVICE).

Who is sponsoring clinical trial NCT02698787?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02698787 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02698787's enrollment target sits among peer trials

11 13th of 13 higher than 1 of 13 other Sensorineural Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02698787, the US trial registry maintained by the National Library of Medicine. NCT02698787 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.